Construction and Validation of TACE Therapeutic Efficacy by ALR Score and Nomogram: A Large, Multicenter Study

References

• Kulik L, El-Serag HB. Epidemiology and management of hepatocellular carcinoma. Gastroenterology. 2019;156(2):477–91.e1. doi:10.1053/j.gastro.2018.08.065
   PubMed Web of Science ®Google Scholar
• Llovet JM, Kelley RK, Villanueva A, et al. Hepatocellular carcinoma. Nat Rev Dis Primers. 2021;7(1):6. doi:10.1038/s41572-020-00240-3
   PubMed Web of Science ®Google Scholar
• Llovet JM, De Baere T, Kulik L, et al. Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol. 2021;18(5):293–313. doi:10.1038/s41575-020-00395-0
   PubMed Web of Science ®Google Scholar
• Benson AB, D’Angelica MI, Abbott DE, et al. Hepatobiliary cancers, version 2.2021, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2021;19(5):541–565. doi:10.6004/jnccn.2021.0022
   PubMed Web of Science ®Google Scholar
• Forner A, Reig M, Bruix J. Hepatocellular carcinoma. Lancet. 2018;391(10127):1301–1314. doi:10.1016/S0140-6736(18)30010-2
   PubMed Web of Science ®Google Scholar
• Sieghart W, Hucke F, Pinter M, et al. The ART of decision making: retreatment with transarterial chemoembolization in patients with hepatocellular carcinoma. Hepatology. 2013;57(6):2261–2273. doi:10.1002/hep.26256
   PubMed Web of Science ®Google Scholar
• Chang Y, Jeong SW, Young Jang J, Jae Kim Y. Recent updates of transarterial chemoembolilzation in hepatocellular carcinoma. Int J Mol Sci. 2020;21(21):8165. doi:10.3390/ijms21218165
   PubMed Web of Science ®Google Scholar
• Kloeckner R, Pitton MB, Dueber C, et al. Validation of clinical scoring systems ART and ABCR after transarterial chemoembolization of hepatocellular carcinoma. J Vasc Interv Radiol. 2017;28(1):94–102. doi:10.1016/j.jvir.2016.06.012
   PubMed Web of Science ®Google Scholar
• Terzi E, Terenzi L, Venerandi L, et al. The ART score is not effective to select patients for transarterial chemoembolization retreatment in an Italian series. Dig Dis. 2014;32(6):711–716. doi:10.1159/000368007
   PubMed Web of Science ®Google Scholar
• Boulin M, Adam H, Guiu B, et al. Predictive factors of transarterial chemoembolisation toxicity in unresectable hepatocellular carcinoma. Dig Liver Dis. 2014;46(4):358–362. doi:10.1016/j.dld.2013.12.012
   PubMedGoogle Scholar
• Tang T, Qiu JL, Li GW, et al. Aspartate aminotransferase-to-platelet ratio predicts response to transarterial chemoembolisation and prognosis in hepatocellular carcinoma patients. Clin Radiol. 2018;73(3):259–265. doi:10.1016/j.crad.2017.09.004
   PubMed Web of Science ®Google Scholar
• Raoul JL, Forner A, Bolondi L, Cheung TT, Kloeckner R, de Baere T. Updated use of TACE for hepatocellular carcinoma treatment: how and when to use it based on clinical evidence. Cancer Treat Rev. 2019;72:28–36. doi:10.1016/j.ctrv.2018.11.002
   PubMed Web of Science ®Google Scholar
• Lei K, Deng ZF, Wang JG, You K, Xu J, Liu ZJ. PNI-based nomograms to predict tumor progression and survival for patients with unresectable hepatocellular carcinoma undergoing transcatheter arterial chemoembolization. J Clin Med. 2023;12(2):486. doi:10.3390/jcm12020486
   PubMed Web of Science ®Google Scholar
• Li J, Li C, Zhu G, et al. A novel nomogram to predict survival of patients with hepatocellular carcinoma after transarterial chemoembolization: a tool for retreatment decision making. Ann Transl Med. 2023;11(2):68. doi:10.21037/atm-22-6513
   PubMedGoogle Scholar
• Oura K, Morishita A, Tani J, Masaki T. Tumor immune microenvironment and immunosuppressive therapy in hepatocellular carcinoma: a review. Int J Mol Sci. 2021;22(11):5801. doi:10.3390/ijms22115801
   PubMed Web of Science ®Google Scholar
• Wu ZH, Yang DL, Wang L, Liu J. Epigenetic and immune-cell infiltration changes in the tumor microenvironment in hepatocellular carcinoma. Front Immunol. 2021;12:793343. doi:10.3389/fimmu.2021.793343
   PubMed Web of Science ®Google Scholar
• Schoenberg MB, Li X, Li X, et al. The predictive value of tumor infiltrating leukocytes in hepatocellular carcinoma: a systematic review and meta-analysis. Eur J Surg Oncol. 2021;47(10):2561–2570. doi:10.1016/j.ejso.2021.04.042
   PubMed Web of Science ®Google Scholar
• Ali MAM, Harmsen WS, Morsy KH, Galal GMK, Therneau TM, Roberts LR. Prognostic utility of systemic inflammatory markers and chronic hepatitis C virus infection status in hepatocellular carcinoma patients treated with local ablation. BMC Cancer. 2022;22(1):221. doi:10.1186/s12885-021-09121-8
   PubMed Web of Science ®Google Scholar
• Zheng X, Jin W, Wang S, Ding H. Progression on the roles and mechanisms of tumor-infiltrating T lymphocytes in patients with hepatocellular carcinoma. Front Immunol. 2021;12:729705. doi:10.3389/fimmu.2021.729705
   PubMed Web of Science ®Google Scholar
• Gao F, Xie K, Xiang Q, et al. The density of tumor-infiltrating lymphocytes and prognosis in resectable hepatocellular carcinoma: a two-phase study. Aging. 2021;13(7):9665–9678. doi:10.18632/aging.202710
   PubMedGoogle Scholar
• Garnelo M, Tan A, Her Z, et al. Interaction between tumour-infiltrating B cells and T cells controls the progression of hepatocellular carcinoma. Gut. 2017;66(2):342–351. doi:10.1136/gutjnl-2015-310814
   PubMed Web of Science ®Google Scholar
• Ventura Y, Carr BI, Kori I, Guerra V, Shibolet O. Analysis of aggressiveness factors in hepatocellular carcinoma patients undergoing transarterial chemoembolization. World J Gastroenterol. 2018;24(15):1641–1649. doi:10.3748/wjg.v24.i15.1641
   PubMed Web of Science ®Google Scholar
• Zhang LX, Lv Y, Xu AM, Wang HZ. The prognostic significance of serum gamma-glutamyltransferase levels and AST/ALT in primary hepatic carcinoma. BMC Cancer. 2019;19(1):841. doi:10.1186/s12885-019-6011-8
   PubMed Web of Science ®Google Scholar
• Peng X, Huang Y, Zhang M, et al. Prognostic and clinical significance of aspartate aminotransferase-to-lymphocyte ratio index in individuals with liver cancer: a meta-analysis. Dis Markers. 2022;2022:3533714. doi:10.1155/2022/3533714
   PubMed Web of Science ®Google Scholar